BackTenax Therapeutics Overview
Tenax Therapeutics Inc

Tenax Therapeutics Target Price

Analysts' average 12-month price target for Tenax Therapeutics is $16.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.78

Average Target Price

$15.50770.8% upside

8 analysts in the last 4 months

High: $40 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-11Chardan Capital$5180.9% upsideOpen
2026-08-11Canaccord Genuity$4124.7% upsideOpen
2026-08-11Guggenheim$4124.7% upsideOpen
2026-08-11Leerink Partners$4124.7% upsideOpen
2026-08-10Roth Capital$5180.9% upsideOpen
2026-07-28Canaccord Genuity$351866.3% upsideOpen
2026-06-22Guggenheim$402147.2% upsideOpen
2026-06-22Chardan Capital$271416.9% upsideOpen
2025-12-17Guggenheim$251304.5% upsideOpen
2025-09-08Piper SandlerYasmeen Rahimi$201023.6% upsideOpen
2025-05-15GuggenheimSeamus Fernandez$15742.7% upsideOpen
2025-03-10Leerink Partners$201023.6% upsideOpen

Tenax Therapeutics (TENX) FAQ

As of the most recent data, TENX shows a target price of $16. Scroll down for historical charts and peer comparison views.

If Tenax Therapeutics moved to the average analyst target of $16, shares would be roughly 770.8% higher than $1.78. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Tenax Therapeutics's earnings trajectory.

Besides this target price page, Stockcircle has Tenax Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $16) with ownership activity and broader fundamentals.

Tenax Therapeutics's target price is $16; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.